Skip to main content

Diabetes, arthritis and other conditionsGuide

Ankylosing spondylitis

Ankylosing spondylitis (AS) is a long-term inflammatory condition that mainly affects the spine and the joints where the spine meets the pelvis, causing back pain, stiffness and tiredness. Anti-inflammatory medicines, regular low-impact exercise and not smoking are the usual first steps. Other treatments are added if these aren't enough.

Reviewed by Andrew Schox, BSc(Hons) PGradDipPod MPodLast reviewed 22 November 2026 6 min read

Jump to a section
  1. 1. What is ankylosing spondylitis, and how common is it?
  2. 2. What causes ankylosing spondylitis, and who gets it?
  3. 3. What does it feel like, how is it diagnosed, and what can make it serious?
  4. 4. What helps first?
  5. 5. What helps if that isn't enough?
  6. 6. What is the outlook, and can it be kept from getting worse?

At a glance

  • It's a long-term inflammatory condition that mainly affects the spine and the joints where the spine meets the pelvis.
  • Back pain that eases with exercise but not rest is the typical pattern, often with morning stiffness.
  • Diagnosis often takes years, because early symptoms look like ordinary back trouble.
  • Anti-inflammatory medicines, regular low-impact exercise and stopping smoking are the usual first steps.
  • Eye and bowel inflammation can go along with AS.

What is ankylosing spondylitis, and how common is it?

Ankylosing spondylitis (AS, also called Bechterew's disease) is a long-term condition in which the spine and other parts of the body become inflamed. It mainly affects the spine and the sacroiliac joints (where the spine meets the pelvis), though other joints, tendons and ligaments can be involved too.

The usual features are back pain with stiffness, pain and swelling elsewhere from joint inflammation and enthesitis (inflammation where a tendon joins a bone), and extreme tiredness. These build up slowly and can flare and settle. Over time, inflammation of the lower spine can damage the spine and cause new bone growth.

AS is one form of axial spondyloarthritis (inflammatory arthritis of the spine). The other form, non-radiographic, lacks the advanced joint damage and spinal fusion that AS shows on X-ray.

Estimates of how common AS is vary. One puts it at 0.1–0.5% of the population, and another at about 1 in 200 people. Rates differ between countries and follow how common the HLA-B27 gene variant is in the population. Most of what is known comes from adults.

What causes ankylosing spondylitis, and who gets it?

The exact cause isn't known. AS is considered autoimmune (the body's defences act against its own tissues), and both genes and environment are believed to play a part. It runs strongly in families.

The gene variant most linked with AS is HLA-B27. Most people with AS carry it, but most carriers never develop AS, so the gene alone isn't a diagnosis or a prediction. A few other genes add to the risk.

Current smoking seems to raise the risk of AS and is tied to how active it is. Whether past smoking matters is less clear. Mechanical stress where tendons attach to bone may help trigger enthesitis. The disease may also start in the gut, though that remains a hypothesis.

What does it feel like, how is it diagnosed, and what can make it serious?

AS usually starts gradually as back pain and stiffness, building over weeks or months and lasting more than three months, often starting before age 45. Several things mark the pain as inflammatory:

  • It feels better with exercise and worse with rest.
  • It can wake you in the second half of the night.
  • Morning stiffness lasts more than 30 minutes and wears off with activity.
  • Buttock pain can switch from side to side.

AS can also bring enthesitis, joint inflammation, tiredness, and swelling of a whole finger or toe (dactylitis). Enthesitis can happen at places such as the sole of the foot or the Achilles tendon. Persistent enthesitis in several places with no clear mechanical cause is one feature that raises the possibility of spondyloarthritis.

There's no single test for AS, and it develops slowly. Normal blood tests for inflammation don't rule it out, and an HLA-B27 result alone can neither confirm nor exclude it. Changes on X-ray often appear years after the back pain starts. Diagnosis takes 8–9 years on average for many people. Early symptoms resemble common back problems, and AS is often mistaken for ordinary mechanical back pain or for unrelated tendonitis and joint problems. That mix-up is a common reason for long delays and for missed eye or bowel problems.

Some features mark AS as more serious:

  • Uveitis (eye inflammation) can go with AS and is more common in people who carry HLA-B27. Painful or red eyes, or vision changes such as blurring, floaters, partial loss of sight or light sensitivity, can signal it.
  • Inflammatory bowel disease can go with AS. Diarrhoea lasting more than two weeks, or bloody or slimy stools, can signal it.
  • Psoriasis (a skin condition) can also accompany spinal disease.

Back pain can also come from serious problems such as cauda equina syndrome (a problem with the nerves at the base of the spine), spinal fracture, cancer or spinal infection, which are assessed urgently.

What helps first?

NSAIDs (non-steroidal anti-inflammatory medicines) have the strongest backing. They ease pain, disease activity and everyday function better than a dummy tablet over about six weeks. They carry their own risks. One type has been linked to a modest rise in heart risk, so the choice of medicine takes other health conditions into account.

Exercise helps keep muscles strong and joints mobile and flexible. Low-impact options such as water exercise may be suggested. Back exercises may not suit everyone: if you are unsure of your fitness, or have a health problem or recent injury, pain or unwellness during exercise can mean a movement isn't suitable for you, and stopping is the response if either occurs.

If you smoke, stopping is advised. AS is more severe in people who smoke, and smoking blunts the effect of treatment.

What helps if that isn't enough?

TNF-α (a protein that drives inflammation) is higher in people with AS, and people with AS respond well to medicines that block it. Starting these early, within 10 years of AS, may give greater benefit. Smoking is linked to a weaker response to them.

Some biologic medicines have been linked to more uveitis than others. Exercise and quitting smoking still matter alongside any medicines. How well insoles, footwear or local treatments for enthesitis work in AS isn't clear yet.

What is the outlook, and can it be kept from getting worse?

Several things are linked to faster changes on X-ray: being male, carrying HLA-B27, existing X-ray changes, a long time with the disease, raised CRP (a blood marker of inflammation), high disease activity, smoking and alcohol. Smoking is also tied to more severe disease. Current smoking is clearly linked with AS, while the role of past smoking is less clear.

To help protect movement, it can help to keep up regular exercise, stop smoking if you smoke, and bring up alcohol intake as part of your overall care. How often flares happen and how long calm spells last isn't clear yet.

Common questions

Is ankylosing spondylitis more common in men than women?

It affects men more often, roughly 2 men for every woman, though that varies a lot between studies. Women tend to wait longer for a diagnosis, so the true gap may be smaller than it looks.

Does ankylosing spondylitis always lead to a fused spine?

No. Over time, inflammation can cause new bone growth, and in some people parts of the spine fuse and lose flexibility. Fusion is not a given for everyone with the condition.

Can ankylosing spondylitis cause heel pain or Achilles tendon pain?

It can cause pain and swelling away from the spine through enthusiasts' enthesitis, which is inflammation where a tendon or ligament attaches to bone. Plantar fasciitis and Achilles tendonitis are listed among the types of enthesitis.

Further reading

Want to know more? Ankylosing spondylitis on Clindice

Reviewed by Andrew Schox, BSc(Hons) PGradDipPod MPod

Podiatrist

Reviewed 22 November 2026. Next review by 22 November 2027.

How we write and review Learn

Was this page helpful?

Sources

(18)
  1. 1.Ankylosing spondylitisNHS · 2026
  2. 2.Back Pain: Suspected Ankylosing Spondylitis & Spondyloarthritis (MSK Rheumatology) – GP GatewayGP Gateway
  3. 3.Ankylosing spondylitis - CausesNHS
  4. 4.2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisWard MM, Deodhar A, Gensler LS et al. · Arthritis & Rheumatology · 2019
  5. 5.Ankylosing spondylitis risk factors: a systematic literature reviewHwang MC, Ridley L, Reveille JD · Clinical Rheumatology · 2021
  6. 6.Global prevalence of ankylosing spondylitisDean LE, Jones GT, MacDonald AG et al. · Rheumatology · 2014
  7. 7.Ankylosing spondylitis: from cells to genesZambrano-Zaragoza JF, Agraz-Cibrian JM, González-Reyes C et al. · International Journal of Inflammation · 2013
  8. 8.Environmental and Genetic Determinants of Ankylosing SpondylitisBilski R, Kamiński P, Kupczyk D et al. · International Journal of Molecular Sciences · 2024
  9. 9.778FM.3 MANAGEMENT OF PATIENTS WITH AXIAL SPONDYLOARTHRITISbucksformulary.nhs.uk
  10. 10.Axial spondyloarthritiswhittington.nhs.uk
  11. 11.Ankylosing spondylitis - DiagnosisNHS
  12. 12.Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitisBraun J, Sieper J · RMD Open · 2023
  13. 13.Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Kroon FPB, van der Burg LRA, Ramiro S et al. · The Cochrane Database of Systematic Reviews · 2015
  14. 14.Current Evidence on Celecoxib Safety in the Management of Chronic Musculoskeletal Conditions: An Umbrella ReviewBeaudart C, Brabant C, Alokail M et al. · Drugs · 2025
  15. 15.Ankylosing SpondylitisNational Institute of Arthritis and Musculoskeletal and Skin Diseases · 2017
  16. 16.Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-AnalysisKarmacharya P, Duarte-Garcia A, Dubreuil M et al. · Arthritis & Rheumatology · 2020
  17. 17.Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease ModificationSari I, Haroon N · Current Rheumatology Reports · 2018
  18. 18.Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritisWebers C, Ortolan A, Sepriano A et al. · Annals of the Rheumatic Diseases · 2023

This is general information, not advice about your own situation. To discuss your issues, book with one of our podiatrists. In an emergency, call 000.

Searching…